Bachelor of Clinical Medicine, Sun Yat-sen University of Medical Sciences (now Zhongshan School of Medicine, Sun Yat-sen University); Doctor of Medicine in Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University; Postdoctoral Fellow, Cedars-Sinai Medical Center, a teaching hospital of UCLA; Visiting Scholar, Inflammatory Bowel Disease Center, University of Southwestern Medical School. **Professional Affiliations:** Deputy Head, Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association Secretary-General, China Inflammatory Bowel Disease Diagnosis and Treatment Quality Control and Evaluation Center Director, Clinical Research Group, Asian Organization for Crohn's and Colitis (AOCC) Vice Chairman, Digestive Endoscopy Branch, Guangdong Medical Doctor Association Published nearly 100 academic papers in domestic and international journals; co-authored 8 monographs. Delivered keynote speeches at numerous major international and domestic academic conferences. **Representative Publications:** 1. Predicting Factors of Long-term Outcome of Gastrointestinal Behcet’s Disease: A Chinese Retrospective Study. Clin Ther. 2024 Jan 30:S0149-2918(24)00005-5. doi: 10.1016/j.clinthera.2023.12.012. 2. Role of Colchicine in Different Clinical Phenotypes of Behcet Disease. Clin Ther. 2023 Feb;45(2):162-176. doi: 10.1016/j.clinthera.2023.01.004. Epub 2023 Feb 1. Erratum in: Clin Ther. 2023 Sep;45(9):923. PMID: 36732153. 3. Mucosal Healing and Quality of Life in Therapeutic Goals of Ulcerative Colitis: Occurrence and Related Factors of Functional Bowel Disorders. Therap Adv Gastroenterol 2022:17562848221092597.doi: 10.1177/17562848221092597 4. Multi-omics Analysis of Western-style Diet Increased Susceptibility to Experimental Inflammatory Bowel Disease. J Inflamm Res 2022 Apr 21;15:2523-2537 5. Diagnosis and Treatment Strategies for IBD Complicated with Rheumatic Diseases (Review). Chinese Journal of Inflammatory Bowel Diseases 2021 6. Advances in Diagnosis and Treatment of Stricturing Crohn's Disease (Review). Chinese Journal of the Frontiers of Medical Science 2021 7. Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study. CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide for the treatment of immune-related bowel disease. J Dig Dis. 2020 Feb;21(2):98-103. 8. Epstein-Barr virus status on clinicopathologic characteristics and clinical outcomes in ulcerative colitis：a study on high incidence area of the viral infection. Therapeutic Advances in Gastroenterology 2020 9. Which Long Noncoding RNAs and Circular RNAs Contribute to Inflammatory Bowel Disease? (Review) Cell death and disease.2020 Jun 15;11(6):456 10. Long-term Efficacy and Safety Analysis of Thalidomide in the Treatment of Refractory Crohn's Disease. Chinese Journal of Internal Medicine, 2020, 59 (6). 11. Development and validation of a novel diagnostic nomogram to differentiate between Intestinal tuberculosis and Crohn’s Disease: A 6-year prospective multi-center study. Am J Gastroenterol 2019 Mar;114(3):490-499 12. Thalidomide induces clinical remission and mucosal healing in adults with active Crohn's disease: a prospective open-label study. Therap Adv Gastroenterol. 2017 May;10(5):397-406 13. The value of empiric anti-tuberculosis therapy in the differential diagnosis between intestinal tuberculosis and Crohn’s disease in China. Int J Clin Exp Med. 2016;9(6):9278-85.( IF: 1.277) 14. Prevalence and influences of hepatitis B virus infection on inflammatory bowel disease: a retrospective study in southern China. Int J Clin Exp Med. 2015;8(5):8078-85.( IF: 1.277) 15. Clinical Characteristics and Influencing Factors of Refractory Crohn's Disease. National Medical Journal of China 2014；94(38): 2982-2987 16. Efficacy and Safety Analysis of Methotrexate in the Treatment of Refractory Crohn's Disease. Chinese Journal of Internal Medicine. 2014; 53(3): 188-192 17. Activation of PI3K/Akt/mTOR signaling pathway triggered by PTEN downregulation in the pathogenesis of Crohn's disease. J Dig Dis. 2013; 14(12): 662-669. 18. Value of PCR Detection of Mycobacterial DNA in Differentiating Crohn's Disease from Intestinal Tuberculosis. Chinese Journal of Pathophysiology. 2013; 29 (1): 188-192 19. Comparison of Clinical and Endoscopic Features between Ileocolonic Crohn's Disease and Intestinal Tuberculosis. Chinese Journal of Digestive Endoscopy. 2012; 26(6): 48-52 20. Research Progress of Thalidomide in the Treatment of Crohn's Disease (Review). Gastroenterology 2012; 9: 570-572 21. Expert Commentary: Diagnosis and Differential Diagnosis of Crohn's Disease. Modern Digestion & Intervention 2010; 15(4): 236-240 22. Expert Commentary: Medical Treatment of Inflammatory Bowel Disease. Journal of Practical Medicine 2003;5(19):453-455